Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A specific proteinase 3 activity footprint in α1-antitrypsin deficiency.

Newby PR, Crossley D, Crisford H, Stockley JA, Mumford RA, Carter RI, Bolton CE, Hopkinson NS, Mahadeva R, Steiner MC, Wilkinson TMA, Sapey E, Stockley RA.

ERJ Open Res. 2019 Aug 5;5(3). pii: 00095-2019. doi: 10.1183/23120541.00095-2019. eCollection 2019 Jul.

2.

The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.

Campos MA, Geraghty P, Holt G, Mendes E, Newby PR, Ma S, Luna-Diaz LV, Turino GM, Stockley RA.

Am J Respir Crit Care Med. 2019 Aug 1;200(3):318-326. doi: 10.1164/rccm.201901-0010OC.

3.

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe.

Hamilton A, Newby PR, Carr-Smith JD, Disanto G, Allahabadia A, Armitage M, Brix TH, Chatterjee K, Connell JM, Hegedüs L, Hunt PJ, Lazarus JH, Pearce SH, Robinson BG, Taylor JC, Vaidya B, Wass JA, Wiersinga WM, Weetman AP, Ramagopalan SV, Franklyn JA, Gough SC, Simmonds MJ.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1459-65. doi: 10.1210/jc.2014-1270. Epub 2014 May 19.

PMID:
24840812
4.

Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis.

Simmonds MJ, Kavvoura FK, Brand OJ, Newby PR, Jackson LE, Hargreaves CE, Franklyn JA, Gough SC.

J Clin Endocrinol Metab. 2014 Jan;99(1):E127-31. doi: 10.1210/jc.2013-2667. Epub 2013 Dec 20.

PMID:
24187400
5.

Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3.

Simmonds MJ, Brand OJ, Barrett JC, Newby PR, Franklyn JA, Gough SC.

Clin Endocrinol (Oxf). 2010 Nov;73(5):654-60. doi: 10.1111/j.1365-2265.2010.03843.x.

6.

Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study.

Newby PR, Pickles OJ, Mazumdar S, Brand OJ, Carr-Smith JD, Pearce SH, Franklyn JA; Wellcome Trust Case-Control Consortium (WTCCC), Evans DM, Simmonds MJ, Gough SC.

Eur J Hum Genet. 2010 Sep;18(9):1021-6. doi: 10.1038/ejhg.2010.55. Epub 2010 May 5.

7.

Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease.

Simmonds MJ, Yesmin K, Newby PR, Brand OJ, Franklyn JA, Gough SC.

Thyroid. 2010 Apr;20(4):413-7. doi: 10.1089/thy.2009.0375.

PMID:
20210668
8.

Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression.

Yesmin K, Hargreaves C, Newby PR, Brand OJ, Heward JM, Franklyn JA, Gough SC, Simmonds MJ.

Clin Endocrinol (Oxf). 2010 Jul;73(1):119-25. doi: 10.1111/j.1365-2265.2010.03780.x. Epub 2010 Feb 10.

PMID:
20148910
9.

CTLA4 polymorphisms and COPD.

Wood AM, Newby PR, Gough SC, Stockley RA.

Eur Respir J. 2010 Feb;35(2):457-8. doi: 10.1183/09031936.00134709. No abstract available.

10.

Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.

Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M, Chatterjee KV, Lazarus JH, Pearce SH, Vaidya B, Gough SC, Franklyn JA.

Am J Med. 2010 Feb;123(2):183.e1-9. doi: 10.1016/j.amjmed.2009.06.030.

PMID:
20103030
11.

Phenotypic differences in alpha 1 antitrypsin-deficient sibling pairs may relate to genetic variation.

Wood AM, Needham M, Simmonds MJ, Newby PR, Gough SC, Stockley RA.

COPD. 2008 Dec;5(6):353-9. doi: 10.1080/15412550802522320. Erratum in: COPD. 2009 Feb;6(1):78.

PMID:
19353349
12.

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.

Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ, Wiersinga WM, Hegedüs L, Connell J, Wass JA, Franklyn JA, Weetman AP, Heward JM, Gough SC.

Hum Mol Genet. 2009 May 1;18(9):1704-13. doi: 10.1093/hmg/ddp087. Epub 2009 Feb 25.

PMID:
19244275
13.

The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency.

Wood AM, Simmonds MJ, Bayley DL, Newby PR, Gough SC, Stockley RA.

Respir Res. 2008 Jul 11;9:52. doi: 10.1186/1465-9921-9-52.

14.

Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease.

Zeitlin AA, Heward JM, Newby PR, Carr-Smith JD, Franklyn JA, Gough SC, Simmonds MJ.

Genes Immun. 2008 Jun;9(4):358-63. doi: 10.1038/gene.2008.26. Epub 2008 May 1.

PMID:
18449200
15.

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.

Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskivina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Farmer A, Williamson R, McGuffin P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop TD, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Dixon RJ, Mangino M, Stevens S, Thompson JR, Bredin F, Tremelling M, Parkes M, Drummond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Matthew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfield JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Lathrop MG, Connell J, Dominiczak A, Marcano CA, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue M, Caulfield M, Farrall M, Barton A; Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering Committee, Bruce IN, Donovan H, Eyre S, Gilbert PD, Hilder SL, Hinks AM, John SL, Potter C, Silman AJ, Symmons DP, Thomson W, Worthington J, Dunger DB, Widmer B, Frayling TM, Freathy RM, Lango H, Perry JR, Shields BM, Weedon MN, Hattersley AT, Hitman GA, Walker M, Elliott KS, Groves CJ, Lindgren CM, Rayner NW, Timpson NJ, Zeggini E, Newport M, Sirugo G, Lyons E, Vannberg F, Hill AV, Bradbury LA, Farrar C, Pointon JJ, Wordsworth P, Brown MA, Franklyn JA, Heward JM, Simmonds MJ, Gough SC, Seal S; Breast Cancer Susceptibility Collaboration (UK), Stratton MR, Rahman N, Ban M, Goris A, Sawcer SJ, Compston A, Conway D, Jallow M, Newport M, Sirugo G, Rockett KA, Bumpstead SJ, Chaney A, Downes K, Ghori MJ, Gwilliam R, Hunt SE, Inouye M, Keniry A, King E, McGinnis R, Potter S, Ravindrarajah R, Whittaker P, Widden C, Withers D, Cardin NJ, Davison D, Ferreira T, Pereira-Gale J, Hallgrimsdo'ttir IB, Howie BN, Su Z, Teo YY, Vukcevic D, Bentley D, Brown MA, Compston A, Farrall M, Hall AS, Hattersley AT, Hill AV, Parkes M, Pembrey M, Stratton MR, Mitchell SL, Newby PR, Brand OJ, Carr-Smith J, Pearce SH, McGinnis R, Keniry A, Deloukas P, Reveille JD, Zhou X, Sims AM, Dowling A, Taylor J, Doan T, Davis JC, Savage L, Ward MM, Learch TL, Weisman MH, Brown M.

Nat Genet. 2007 Nov;39(11):1329-37. Epub 2007 Oct 21.

16.

Tag SNP screening of the PDCD1 gene for association with Graves' disease.

Newby PR, Roberts-Davies EL, Brand OJ, Heward JM, Franklyn JA, Gough SC, Simmonds MJ.

Clin Endocrinol (Oxf). 2007 Jul;67(1):125-8. Epub 2007 May 9.

PMID:
17490403
17.

Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.

Zeitlin AA, Heward JM, Brand OJ, Newby PR, Franklyn JA, Gough SC, Simmonds MJ.

Clin Endocrinol (Oxf). 2006 Sep;65(3):380-4.

PMID:
16918960

Supplemental Content

Loading ...
Support Center